Publications by authors named "Ann-Lii Cheng"

100Publications

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply.

N Engl J Med 2020 08;383(7):695

National Taiwan University Cancer Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2021840DOI Listing
August 2020

A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women.

Environ Int 2020 Sep 21;142:105850. Epub 2020 Jun 21.

Institute of Environmental and Occupational Health Sciences, College of Public Health, National Taiwan University, Taipei 100, Taiwan; Department of Public Health, National Taiwan University College of Public Health, Taipei 100, Taiwan; Department of Environmental and Occupational Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan; Office of Occupational Safety and Health, National Taiwan University College of Medicine and Hospital, Taipei 100, Taiwan; Innovation and Policy Center for Population Health and Sustainable Environment, National Taiwan University College of Public Health, Taipei 100, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envint.2020.105850DOI Listing
September 2020

Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design.

Future Oncol 2020 Jul 3;16(21):1525-1536. Epub 2020 Jun 3.

Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2020-0283DOI Listing
July 2020

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

N Engl J Med 2020 05;382(20):1894-1905

From the Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA, Los Angeles (R.S.F.), the City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte (D.L.), and Genentech, South San Francisco (W.V., S.H., Y.W.) - all in California; the People's Liberation Army Cancer Center, Jinling Hospital, Nanjing (S.Q.), and Roche Product Development (D.-Z.X., J.L., C.H.) and Jiahui International Cancer Center, Jiahui Health (A.X.Z.), Shanghai - all in China; National Cancer Center Hospital East, Kashiwa (M.I.), and Kindai University Faculty of Medicine, Osaka (M.K.) - both in Japan; University Medical Center Mainz, Mainz, Germany (P.R.G.); Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif (M.D.), and University Hospital La Croix-Rousse, Lyon (P.M.) - both in France; Seoul National University College of Medicine (T.-Y.K.) and Samsung Medical Center, Sungkyunkwan University School of Medicine (H.Y.L.) - both in Seoul, South Korea; N.N. Blokhin Russian Cancer Research Center, Moscow (V.B.); the University of Texas M.D. Anderson Cancer Center, Houston (A.O.K.); Hoffmann-La Roche, Mississauga, ON, Canada (S.M.); Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston (A.X.Z.); and the National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei (A.-L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1915745DOI Listing
May 2020

IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation.

Future Oncol 2020 May 30;16(15):975-989. Epub 2020 Apr 30.

PLA Cancer Center, People's Liberation Army (PLA) 81 Hospital, Nanjing 210016, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2020-0162DOI Listing
May 2020

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer.

Clin Transl Radiat Oncol 2020 May 23;22:76-82. Epub 2020 Mar 23.

Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctro.2020.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139144PMC
May 2020

Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.

J Hepatol 2020 02;72(2):307-319

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.09.025DOI Listing
February 2020

Milestones in the pathogenesis and management of primary liver cancer.

J Hepatol 2020 02;72(2):209-214

Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Translational Research in Hepatic Oncology Group, Liver Unit, IDIBAPS, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.11.006DOI Listing
February 2020

Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.

J Hepatol 2020 03 18;72(3):489-497. Epub 2019 Oct 18.

Department of Medical Oncology, National Taiwan University Cancer Center, Taiwan; Department of Oncology, National Taiwan University Hospital, Taiwan; Graduate Institute of Oncology, School of Medicine, National Taiwan University, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.09.032DOI Listing
March 2020

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma.

Cancers (Basel) 2019 Sep 26;11(10). Epub 2019 Sep 26.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei 10051, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11101433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827105PMC
September 2019

Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness.

World J Gastrointest Oncol 2019 Aug;11(8):579-588

Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4251/wjgo.v11.i8.579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700034PMC
August 2019

Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma.

Liver Int 2019 11 31;39(11):2184-2189. Epub 2019 Aug 31.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14210DOI Listing
November 2019

Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection.

J Formos Med Assoc 2020 Jan 22;119(1 Pt 2):335-344. Epub 2019 Jun 22.

Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2019.05.027DOI Listing
January 2020

Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.

Expert Rev Gastroenterol Hepatol 2019 Jul 27;13(7):615-621. Epub 2019 May 27.

b Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474124.2019.1
Publisher Site
http://dx.doi.org/10.1080/17474124.2019.1621165DOI Listing
July 2019

Novel Insights of Lymphomagenesis of -Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.

Cancers (Basel) 2019 Apr 17;11(4). Epub 2019 Apr 17.

Cancer Research Center, National Taiwan University College of Medicine, Taipei 100, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11040547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520890PMC
April 2019

Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients.

J Formos Med Assoc 2020 Jan 7;119(1 Pt 1):97-105. Epub 2019 Mar 7.

Department of Oncology, National Taiwan University Hospital, Taiwan; Graduate Institutes of Clinical Medicine, National Taiwan University College of Medicine, Taiwan; Graduate Institutes of Oncology, National Taiwan University College of Medicine, Taiwan; National Taiwan University Cancer Center, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2019.01.015DOI Listing
January 2020

Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma.

Liver Int 2019 09 11;39(9):1682-1691. Epub 2019 Jul 11.

Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.14055
Publisher Site
http://dx.doi.org/10.1111/liv.14055DOI Listing
September 2019

CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer.

Oncology 2019 12;96(3):156-163. Epub 2018 Dec 12.

Department of Oncology, National Taiwan University Hospital, Taipei City, Taiwan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000493387DOI Listing
March 2019

Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma.

J Formos Med Assoc 2019 Jun 28;118(6):1024-1030. Epub 2018 Nov 28.

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, No 1, Jen Ai Road Section 1, Taipei, 10051, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2018.11.003DOI Listing
June 2019

Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.

Semin Liver Dis 2018 Nov 24;38(4):379-388. Epub 2018 Oct 24.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1673621
Publisher Site
http://dx.doi.org/10.1055/s-0038-1673621DOI Listing
November 2018

Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer.

Radiat Oncol 2018 Aug 28;13(1):157. Epub 2018 Aug 28.

Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-1099-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114480PMC
August 2018

Corrigendum to "Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies" [J hepatol 67 (2017) 999-1008].

J Hepatol 2018 Oct 10;69(4):990-991. Epub 2018 Aug 10.

Hepatic Oncology, BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; Mount Sinai Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.07.015DOI Listing
October 2018

A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma.

Anticancer Res 2018 Aug;38(8):4805-4812

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12790DOI Listing
August 2018

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

N Engl J Med 2018 Jul;379(1):54-63

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (G.K.A.-A.); Royal Free Hospital and University College London, London (T.M.); National Taiwan University Hospital, Taipei (A.-L.C.), and the Department of Medical Oncology, Liouying Chi Mei Hospital, Tainan (Y.C.) - both in Taiwan; USC Norris Comprehensive Cancer Center, Los Angeles (A.B.E.-K.), UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (A.P.V., R.K.K.), and Exelixis, Alameda (C.H., A.E.B.-H., G.S.) - all in California; Humanitas Cancer Center, Humanitas Clinical and Research Center, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano (L.R., T.P.), the Department of Medical and Surgical Sciences, University of Bologna, Bologna (L.B.), and Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padua (V.Z.) - all in Italy; Asan Medical Center, University of Ulsan College of Medicine, Seoul (B.-Y.R., M.-H.R.), and the National Cancer Center, Goyang (J.-W.P.) - both in South Korea; Trakya University School of Medicine, Edirne, Turkey (I.C.); Groupement Hospitalier Nord, Lyon (P.M.), and Hôpital Haut-Lévêque, Centre Hospitalier Universitaire Bordeaux, Bordeaux (J.-F.B.) - both in France; the Department of Medical Oncology, Academic Medical Center, Amsterdam (H.-J.K.); and the Chinese University of Hong Kong, State Key Laboratory in Oncology in South China, Hong Kong (S.L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1717002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523244PMC
July 2018

The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.

Theranostics 2018 9;8(12):3176-3188. Epub 2018 May 9.

Institute of Biomedical Sciences, Academia Sinica, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.23207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010982PMC
August 2019

Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.

Eur Radiol 2018 Nov 16;28(11):4860-4870. Epub 2018 May 16.

Department of Radiology, College of Medicine, National Taiwan University, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-018-5448-5DOI Listing
November 2018

Effect of glucocorticoid use on survival in patients with stage I-III breast cancer.

Breast Cancer Res Treat 2018 Aug 14;171(1):225-234. Epub 2018 May 14.

School of Health Care Administration, Taipei Medical University, No. 172-1, Keelung Road, Section 2, Taipei, 106, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4787-xDOI Listing
August 2018

Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.

J Hepatol 2018 08 16;69(2):286-292. Epub 2018 Mar 16.

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; National Taiwan University Cancer Center, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.02.033DOI Listing
August 2018

Targeting tumor-infiltrating Ly6G myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma.

Int J Cancer 2018 05 26;142(9):1878-1889. Epub 2017 Dec 26.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31216DOI Listing
May 2018

Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.

Anticancer Res 2017 12;37(12):7095-7104

Graduate Institute of Oncology, College of Public Health, National Taiwan University, Taipei, Taiwan, R.O.C

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12183DOI Listing
December 2017

Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells.

Oncotarget 2017 Oct 30;8(49):86681-86692. Epub 2017 Sep 30.

Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689717PMC
October 2017

Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas.

Oncotarget 2017 Oct 15;8(46):81329-81342. Epub 2017 Jun 15.

Department of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655287PMC
October 2017

Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma".

J Hepatol 2018 03 24;68(3):620-621. Epub 2017 Oct 24.

BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Spain; Mount Sinai Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.10.013DOI Listing
March 2018

High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma.

Jpn J Clin Oncol 2017 Oct;47(10):949-953

Graduate Institute of Oncology, National Taiwan University College of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx103DOI Listing
October 2017

Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma.

Hepatology 2018 03 1;67(3):1132-1149. Epub 2018 Feb 1.

Medical Oncology Department, Beaujon University Hospital, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873445PMC
March 2018

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies.

J Hepatol 2017 11 4;67(5):999-1008. Epub 2017 Jul 4.

Hepatic Oncology, BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; Mount Sinai Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.026DOI Listing
November 2017

Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.

Hepatology 2018 02 26;67(2):586-599. Epub 2017 Dec 26.

Graduate Institutes of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.29328
Publisher Site
http://dx.doi.org/10.1002/hep.29328DOI Listing
February 2018

Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.

Anticancer Res 2017 05;37(5):2593-2599

Graduate Institute of Oncology, National Taiwan University, Taipei, Taiwan, R.O.C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11604DOI Listing
May 2017

Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

J Hepatol 2017 06 13;66(6):1334-1335. Epub 2017 Mar 13.

Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.02.021DOI Listing
June 2017

Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

J Hepatol 2017 03 6;66(3):666-668. Epub 2017 Jan 6.

Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.12.007DOI Listing
March 2017

Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.

Oncotarget 2017 Jan;8(5):7921-7934

Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13855DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352371PMC
January 2017

Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.

Eur Radiol 2017 Jul 12;27(7):3069-3079. Epub 2016 Dec 12.

Department of Medical Imaging and Radiology, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-016-4670-2DOI Listing
July 2017

Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.

Radiology 2016 Nov 12;281(2):454-464. Epub 2016 May 12.

From the Department of Medical Imaging and Radiology (B.B.C., C.Y.H., C.W.Y., P.C.L.) and Department of Oncology (C.H., C.H.H., A.L.C.), National Taiwan University College of Medicine and Hospital, Taipei, Taiwan; Department of Radiology (C.Y.H.), Taipei Hospital, Ministry of Health and Welfare, New Taipei, Taiwan; and Department of Medical Imaging, Taipei City Hospital, No 7 Chung-Shan South Rd, Taipei 10016, Taiwan (T.T.F.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2016152659DOI Listing
November 2016

Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer.

Support Care Cancer 2017 02 4;25(2):533-539. Epub 2016 Oct 4.

Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Rd, Taipei, 10002, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3434-5DOI Listing
February 2017

Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.

World J Gastroenterol 2016 Aug;22(32):7275-88

Shih-Hung Yang, Jhe-Cyuan Guo, Chiun Hsu, Chih-Hung Hsu, Kun-Huei Yeh, Ann-Lii Cheng, Sung-Hsin Kuo, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei 100, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i32.7275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997635PMC
August 2016

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice.

J Cancer 2016 7;7(11):1515-23. Epub 2016 Jul 7.

7. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan; 8. Taiwan Cancer Registry, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.15180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964135PMC
July 2016

Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.

Ann Surg Oncol 2016 11 19;23(12):3860-3869. Epub 2016 Jul 19.

Department of Surgery, National Taiwan University Hospital and National Taiwan University Cancer Center, No. 7, Chung-Shan South Road, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5435-5DOI Listing
November 2016

Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.

Cancer Lett 2016 10 16;381(1):58-66. Epub 2016 Jul 16.

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.07.013DOI Listing
October 2016

A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer.

BMC Cancer 2016 07 13;16:466. Epub 2016 Jul 13.

Department of Medical Imaging and Radiology, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2494-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944505PMC
July 2016

Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges.

Liver Cancer 2016 Apr 17;5(2):128-38. Epub 2016 Mar 17.

Departments of Oncology, National Taiwan University Hospital, Taipei, Taiwan (ROC); Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (ROC); Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan (ROC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000367754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906428PMC
April 2016